Brain bank of the Brazilian aging brain study group a milestone reached and more than 1,600 collected brains

Size: px
Start display at page:

Download "Brain bank of the Brazilian aging brain study group a milestone reached and more than 1,600 collected brains"

Transcription

1 Cell Tissue Banking (2007) 8: DOI /s z Brain bank of the Brazilian aging brain study group a milestone reached and more than 1,600 collected brains Lea Tenenholz Grinberg Æ Renata Eloah de Lucena Ferretti Æ José Marcelo Farfel Æ Renata Leite Æ Carlos Augusto Pasqualucci Æ Sérgio Rosemberg Æ Ricardo Nitrini Æ Paulo Hilário Nascimento Saldiva Æ Wilson Jacob Filho Æ Brazilian Aging Brain Study Group Received: 16 April 2006 / Accepted: 5 July 2006 / Published online: 31 October 2006 Ó Springer Science+Business Media B.V Abstract Introduction Brain banking remains a necessity for the study of aging brain processes and related neurodegenerative diseases. In the present paper, we report the methods applied at and the first results of the Brain Bank of the Brazilian Aging Brain Study Group (BBBABSG) which has two main aims: (1) To collect a large number of brains of elderly comprising non-demented subjects and a large spectrum of pathologies related to aging brain processes, (2) To provide quality material to a multidisciplinar research network unraveling multiple aspects of aging brain processes and related neurodegenerative diseases. Methods The subjects are selected from the Sao Paulo Autopsy Service. Brain parts are L. T. Grinberg (&) Æ R. E. de Lucena Ferretti Æ R. Leite Æ C. A. Pasqualucci Æ S. Rosemberg Æ P. H. N. Saldiva Department of Pathology, University of Sao Paulo Medical School, Avenida Dr. Arnaldo, 455 1st floor, room 1351, Sao Paulo, SP , Brazil leagrinberg@usp.br J. M. Farfel Æ W. Jacob Filho Division of Geriatrics, University of Sao Paulo Medical School, Sao Paulo, SP, Brazil R. Nitrini Department of Neurology, University of Sao Paulo Medical School, Sao Paulo, SP, Brazil frozen and fixated. CSF, carotids, kidney, heart and blood are also collected and DNA is extracted. The neuropathological examinations are carried out based on accepted criteria, using immunohistochemistry. Functional status are assessed through a collateral source based on a clinical protocol. Protocols are approved by the local ethics committee and a written informed consent form is obtained. Results During the first 21 months, 1,602 samples were collected and were classified by Clinical Dementia Rating as CDR0: 65.7%; CDR0.5:12.6%, CDR1:8.2%, CDR2:5.4%, and CDR3:8.1%. On average, the cost for the processing each case stood at US$400. To date, 14 laboratories have been benefited by the BBBABSG. Conclusion The high percentage of nondemented subjects and the ethnic diversity of this series may be significantly contributive toward aging brain processes and related neurodegenerative diseases understanding since BBBABSG outcomes may provide investigators the answers to some additional questions. Keywords Aging Æ Alzheimer s disease Æ Brain banking Æ Dementia Æ Geriatrics Æ Neurodegenerative diseases Æ Neurology Æ Neuropathology

2 152 Cell Tissue Banking (2007) 8: Abbreviations BBASG Brazilian Brain Aging Study Group BBBABSG Brain Bank of the Brazilian Aging Brain Study Group CNS Central nervous system CS Collateral source ICF Informed consent form NOK Next-of-kin PMI Postmortem interval SPAS Sao Paulo autopsy service USPMS University of Sao Paulo Medical School Introduction The world s elderly population is expected to increase four times from 2000 to 2050 (UN Population Division 2000). This will inevitably be followed by a great increase in the prevalence of related neurodegenerative diseases particularly, in developing countries (Ferri et al. 2005; Herrera et al. 2002). Animal models on age-related human diseases mimic the complex pathogenic interactions within the highly evolved human CNS only in a limited manner. Therefore, in order to elucidate environmental, genetic, and endogenous processes in human aging and in neurodegenerative diseases investigation on human brain tissue is precondition. For that reason, brain banks gained an important function during the last years as autopsy is the only practical way in which human brain tissue can be assessed (Cruz-Sanchez and Tolosa 1993). However, considering the high complexity of the brain anatomy and function, a proper brain bank have to be a scientific facility, conducted by multiprofessional experts who assess the subject s cognitive and functional status, and where the material is processed following high standard protocols (Love 2004). Although there are many successful brain banks (Hulette 2003; Orr et al. 2005), the majority of them are affected by the inhered consequences of the worldwide dramatic decreased autopsy rates of past decades resulting in: a low number of enrolled subjects, mainly the non-demented cases; a lack of objective information about comorbidities in brain-only autopsies; and long postmortem interval (PMI). In the present paper, we report the methods applied at and the first results of the Brain Bank of the Brazilian Aging Brain Study Group (BBBABSG). This brain bank has two main aims: (1) To perform a large number of autopsies of elderly individuals; the donors come to autopsy through a general autopsy service, followed by specific dissection protocols. The collected cases should comprise a large number of non-demented subjects and a vast spectrum of pathologies related to aging brain processes. (2) To provide high quality material to a multidisciplinar research network unraveling multiple aspects of aging brain processes and related neurodegenerative diseases. Methods Core board The BBBABSG has been created in September 2003 by the core board of the Brazilian Brain Aging Study Group (BBASG). BBASG is composed by a group of different specialists from the University of Sao Paulo Medical School (USPMS) (Fig. 1). Quality control The first months were fully dedicated to the study design and pilot tests. Clinical scales and questionnaires were discussed and tested in the USPMS Cognitive Study Center, a multidisciplinar research facility. Meanwhile, both the pathological protocol and the electronic database were formatted based on previous successful experiences (Cruz-Sanchez and Tolosa 1993). In 2004, following a study involving all the clinical and pathological steps, BBBABSG began to work under full power. In order to keep the BBBABSG up-to-date and improve its quality, communication with other brain banks like the Netherlands Brain Bank and the Washington University in St. Louis Brain Bank is carefully maintained, including on-site visits and fellowships.

3 Cell Tissue Banking (2007) 8: Fig. 1 Brazilian Brain Aging Study Group s board members Ethical issues BBBABSG s procedures are approved by the Ethical Board of USPMS and by the Brazilian Federal Health Department. The ethical principles follow Brazilian requirements (1996), which are based on international standards, such as The Belmont Report (National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research 1978) and The Helsinki Declaration (1964). A voluntary Informed Consent Form (ICF) is obtained by the interviewer and must be signed by each next-of-kin (NOK) before any procedure. The ICF details research procedures (including image, molecular and genetic studies), purposes, risks and benefits, as well as a statement offering the NOK the opportunity to ask questions and to withdraw at any time from the study. If any of the procedures is refused by the NOK, the case is not banked. All the material used for any purpose is anonymous and the specimens are coded by number. However, specimen identification can be retrieved in case of legal or public health requirements, according to Brazilian regulations. Source of subjects In Sao Paulo, autopsies are compulsory for those who have died in the metropolitan areas with no established cause of death, at no charge to the family. The Sao Paulo Autopsy Service (SPAS) is the site of all autopsies of natural deaths from this city of 11 million people. SPAS has functioned 24 h a day since 1931 and is located within USPMS, adjacent to the BBBABSG s facilities. All autopsies complete and documented, are performed by a medically qualified pathologist assisted by nationally certified technicians. Brains are obtained at autopsy of subjects aged 50 years or older and sourced from the SPAS. BBBABSG s procedures Only the centralized Municipal Autopsy Service is allowed to transport deceased bodies. The time frame is 2 6 h from the hospital or home to SPAS resulting in a short PMI mean of 10.4 h (4 20 h). BBBABSG is structured into five areas (Fig. 2). Reception, selection and informed consent Reception and selection (Fig. 3) Subjects are enrolled from Monday through Friday, between 8 and 18 h. Two rotating teams of two experienced gerontologists each are on shift at the SPAS during this period. Deceased

4 154 Cell Tissue Banking (2007) 8: B B B A B S G RECEPTION, SELECTION AND INFORMED CONSENT CLINICAL AND FUNTIONAL ASSESSMENT NEUROPATHOLOGICAL PROCEDURES DNA BANK ELETRONIC DATABASE Fig. 2 Brain Bank of the Brazilian Aging Brain Study Group structure. Sao Paulo, 2006 information is received in SPAS before the corpse s arrival, allowing a subject pre-selection. The NOK must come personally to SPAS in order to give release of the body. Upon arrival, the NOK waits around 3 h for autopsy procedures and the release of documents. If the consent is granted and a satisfactory collateral source (CS) is on-site, the clinical and functional interview is conducted in a private room. The NOK and the CS are not necessarily the same person. During the interview, the gerontologist judges whether there is enough information available to rate the subject, as well as whether the CS is reliable. The subject is excluded from the study if any of these criteria is not fulfilled. Selection criteria Inclusion criteria: (i) Subjects aged 50 years old and older. Exclusion criteria: (i) Subjects with macroscopically detectable acute brain infarctions, hemorrhages or trauma, since an immediate examination is required for filling the death certificate. (ii) Subjects with severe chronic conditions that might damage cognitive function prior to death by interfering in brain homeostasis. These conditions include severe heart failure, chronic kidney failure and brain metastasis. (iii) Subjects without reliable CS to provide enough information or to appropriately answer the clinical and functional interview. Eligible CS are expected to have at least close weekly contact with the diseased subject during the last 6 months. (iv) Subjects with indication of acidosis due to severe agonal status (CSF ph < 6.5), which makes the tissue incompatible for biochemical and molecular studies (Ravid et al. 1992; Harrison 1996). Fig. 3 Flowchart of the Brain Bank of the Brazilian Aging Brain Study Group s procedures 2006

5 Cell Tissue Banking (2007) 8: Clinical and functional assessment Although the 40 min interview is usually done during the waiting period at SPAS, it may be rescheduled for a later date during the following few days, in case of any impediment. The subject s clinical and functional statuses are assessed through the CS. The protocol includes a series of semi-structured scales and questionnaires that cover major functional abilities and are validated for assessment with an informant (Table 1) (Morris et al. 1991; Isella et al. 2006). Additional information is collected from medical records when available. Moreover, information concerning demographics, medication, medical history, cardiovascular risk factors, and family history of dementia is also collected. Neuropathological procedures (Fig. 3) The procedures are divided into three steps: (1) during autopsy procedure, (2) immediately after autopsy, and (3) during post-fixation (Fig. 3). Steps 1 and 2 are done by three alternating teams composed of three biomedicine undergraduates and one graduate student each. During Step 3, tissue processing and staining are performed by histotechnicians. The materials are analyzed macroscopically and microscopically by the pathologists (Fig. 3). Autopsy is performed by the SPAS pathologist on shift. Step 1 Body weight, height and skull size are measured. CSF is extracted in situ, from the lateral ventricles by transcallosal puncture. Blood is taken from the aorta. Brain, heart, cervical carotids and a kidney sample are removed. Step 2 The brain and heart are measured (weight and volume) and digitally photographed. Three samples of 1 1 cm each are taken from selected areas are snap frozen in labeled cryotubes (Table 2). The Circle of Wills is dissected, photographed and fixed. Subsequently, the brain (suspended), heart, and carotids are fixed. All the material is fixed in 4% buffered paraformaldehyde for 3 weeks. Step 3 All the procedures are done in the BBBABSG s laboratory, located one floor above the SPAS. Any surplus tissue is discarded and buried according to Brazilian regulations. Macroscopic analyzes Brain After cerebellum and brainstem separation by a cut at the level of the superior colliculus, the brain Table 1 Scales used in Brain Bank of the Brazilian Aging Brain Study Group for the clinical and functional assessment 2006 Domain Scales Cognitive Clinical Dementia Rating Scale CDR (Morris 1993) Informant questionnaire of the cognitive decline in the elderly IQCODE (Jorm 1994) Behavioral changes Neuropsychiatric Inventory NPI (Cummings et al. 1994) Affective disorders DSM IV SCID for depression and manic disorders (Del-Ben et al. 1996; Spitzer et al. 1992) Functional assessment The Katz Index (Katz et al. 1963) Instrumental activities of daily living (Lawton and Brody 1969) Parkinson disease Tanner et al. (1990) Social information ABIPEME a Brazilian scale used to determine social-economic condition (Almeida and Wickerhauser 1991)

6 156 Cell Tissue Banking (2007) 8: Table 2 Types of tissues collected and their respective procedure of sampling Brain Bank of the Brazilian Aging Brain Study Group. Sao Paulo, 2006 Area Brain Other tissue Middle frontal (BA46) Superior and inferior parietal lobule (BA 39/40) Superior and middle temporal (BA21/22) Superior frontal (BA8/9) and anterior cingulate (BA24), at the level of the anterior basal ganglia Occipital lobe (BA17/18) Anterior hippocampal formation, entorhinal region (BA27/28) and the inferior temporal (BA20) Amygdala Thalamus Basal ganglia, including the nucleus basalis of Meynert, at the level of the anterior commissure Midbrain including the substantia nigra Pons including locus ceruleus Medulla oblongata Cerebellum, including the dentate nucleus Circle of Willis Cervical carotids Heart Kidney sample CSF Arterial blood Stored at 80 C Stored at 4 C X X X X X X X b b b b u u Fixed X X X X X X X X X X X X X X X X X Embedded X X X X X X X X X X X X X X X X in paraffin X X = sampled; b = bilateral; u = unilateral Note: Paraffin blocks measure cm each

7 Cell Tissue Banking (2007) 8: is coronally sliced in 1 cm slabs. A minimal set of 13 areas is represented and embedded in paraffin blocks (Table 2). The remaining tissue is stored in covered plastic boxes. Cardiovascular In order to assess cardiovascular changes which might be related to cognitive impairment, carotids, coronaries and Circle of Willis arteries are examined semiquantitatively, both macroscopically and microscopically. In every artery, the atherosclerosis level is graded as: none, mild, moderate or severe, and the most obstructed part is sampled and measured microscopically. The ventricular thickness is measured and the heart valves are examined for assessing the occurrence of high blood pressure effects over the heart. These procedures are performed by a specialist following a protocol. Histological technique and staining methods All paraffin blocks are sectioned 8 lm thick and stained with hematoxylin-eosin (HE) and modified Bielschowsky silver impregnation methods. Routine immunohistochemistry is performed on selected areas (Table 3) using antibodies against the following peptides or proteins: b-amyloid, phosphorylated tau, a-synuclein and ubiquitin (Table 4). If suspected lesions are found in the other samples, additional immunostaining is performed. The kidney sample is stained with HE and Masson s trichromic for assessing signs of kidney damage due pressure and atherosclerosis. Histological assessment and diagnosis criteria The histological assessments are based on the most accepted criteria for age-related neurodegenerative diseases (Mirra et al. 1991; Braak and Braak 1991; Braak et al. 2004; McKeith et al. 1996; NIA-RR 1997; McKhann et al. 2001; Saito et al. 2004). Vascular pathology is recorded by area, size and type. DNA bank DNA is extracted from blood samples up to 7 days after the autopsy and is frozen at 80 C. The DNA procedure is coordinated by Mayana Zatz, Ph.D., Director of the Human Genomics Research Center. Eletronic database An SQL-based database was built to store and analyze the data. This work is coordinated by Helena Brentani, MD, Ph.D., Director of the Bioinformatics Laboratory of Hospital A.C Camargo Sao Paulo. This laboratory has contributed to the building of the Sao Paulo Cancer Genomics Project s database (Brentani et al. 2003). Data are loaded in each procedure step. The database is password protected, and backups are done daily. Table 3 Antibodies used routinely in Brain Bank of the Brazilian Aging Brain Study Group Protein name Clone (source) Dilution Antigenal-retrieval treatment Detecton system Chromogen b-amyloid Tau a-synuclein Ubiquitin 4G8 (Signet Pathology Systems) PHF-1 (Gift of P. Davies) a-synuclein (Chemicon) Anti-ubiquitin polyclonal (DAKO) 1:10,000 Steam, citrate ph 6 1:2,000 Steam, citrate ph 6 Vectastain ABC Kit Vectastain ABC Kit (Mouse IgG) Vector Laboratories (Mouse IgG) 1:500 Steam, citrate ph 6 Vectastain ABC Kit (Mouse IgG) 1:5,000 Steam, citrate ph 6 Vectastain ABC Kit (Mouse IgG) DAB DAB DAB DAB

8 158 Cell Tissue Banking (2007) 8: Table 4 Staining protocol for brain areas. Brain Bank of the Brazilian Aging Brain Study Group 2006 Cerebellum Medulla oblongata Midbrain Pons including locus ceruleus Amygdala Thalamus Basal ganglia, including the nucleus basalis of Meynert, Anterior hippocampal formation, entorhinal region (BA27/28) and the inferior temporal (BA20) Occipital lobe (BA17/18) Superior frontal (BA8/9) and anterior cingulate (BA24) Superior and middle temporal (BA21/22) Superior and inferior parietal lobule (BA 39/40) Area Middle frontal (BA46) 4G8 X X X X X X X X X Tau 2 X X X X X X X X X X X X a-synuclein X X X X X X X X X X = stained. Ubiquitin immunohistochemistry is performed if Frontotemporal Lobar Degeneration is suspected Tissue request Research groups may access material for studies on the aging process and related neurodegenerative diseases. The request, together with the proof of ethics approval from the parent institution, is evaluated by the BBBABSG core board. An annual report from each participating research group should be done. No tissue may be redistributed without authorization from the BBBABSG. Results Sample characteristics From April 2004 to December 2005, 1,602 out of the 2,769 possible subjects were enrolled. The number of deaths in older age groups as well as enrolled subjects increased during the winter. Although the percentage of possible subjects successfully banked is around 50%, approximately 9% of the NOKs declined to participate in this study, mainly due a lack of interest in the proposed study. Possible subjects are excluded by either CS or subject-dependent variables, such as lack of reliability or agonal state severity, respectively. (Fig. 4) The series mean age is 71.2 years for females and 66.5 years for males, following the life expectancy data for Sao Paulo City. However, males are slightly more represented in general (Fig. 5). Table 5 summarizes additional results regarding ethnic distribution. It is noteworthy that 2/3 of the subjects are non-cognitive impaired (CDR = 0) (Fig. 6). The cost per successfully banked specimen was about US$400 per case. Tissue request To date, BBBAGSG is providing tissue for five kinds of studies: neuropathological, neurochemical, molecular, neuroimaging and epidemiological, which are being conducted in 14 research laboratories from both USPMS and outside.

9 Cell Tissue Banking (2007) 8: Fig. 4 Time line of Brain Bank of the Brazilian Aging Brain Study Group series from April 2004 to December 2005 (in absolute numbers) Possible subjects = 2, Enrolled subjects = 1, Excluded due to selection criteria = Excluded due to CS = Refused =148 0 jul/04ago/04set/04out/04nov/04dez/04jan/05 fev/05mar/05abr/05mai/05jun/05 jul/05ago/05set/05out/05nov/05dez/05jan/06 Discussion Our first results show the feasibility of brain bank based on a large general autopsy service that prospectively prepares and stores specimens to satisfy most research requirements for aging processes and related neurodegenerative studies. Furthermore, the large amount of available subjects affords strict selection criteria minimizing the pitfalls related to this kind of study design. In summary, some local characteristics are positive assets to BBBABSG, such as: (a) (b) (c) The large number of autopsies done at SPAS, leading to a large number of possible subjects, consequently facilitating control-case matching and continuous specimen replacement, The location of SPAS within the USPMS, adjacent to the Pathology Department, narrowing postmortem delay and avoiding transportation damage, The broad heterogeneity of the Sao Paulo population, resulting in an ethnically diverse sample (BBBABSG hosts 160 African and 19 Oriental subjects.), Fig. 5 Brain Bank of the Brazilian Aging Brain Study Group series. Subjects distribution by gender and age group

10 160 Cell Tissue Banking (2007) 8: Table 5 Ethnic group distribution Brain Bank of the Brazilian Aging Brain Study Group Ethnic group (%) 65.7% African 10 Caucasian 76.6 Mixed 11 Orientals 1.2 Not available 1.2 (d) The large amount of control subjects (65.7%), a group extremely important to neurodegenerative disease studies and scarcely represented in some series (Murphy and Ravina 2003; Ravid et al. 1995). Furthermore, most of the mild affected subjects are drug-naïve, (e) The high quality of material obtained with low maintenance costs. Each successfully banked specimen cost US$400 in direct and indirect cost, while in the USA the costs range from $10,000 to $30,000 (Hulette 2003). Given that SPAS is an already-established service which boasts structured technical support, the costs are due to consumables, and (f) Complete autopsy results and objective cardiovascular evaluation even careful clinical and laboratory assessment may show discrepancies with autopsy data (Roulson et al. 2005). Given that some cardiovascular risk factors are implied in dementia (Luchsinger et al. 2005), a number of studies stress the importance of objective vascular evaluation through autopsy. The desirable design for a neurodegenerative brain bank is based on longitudinally assessed subjects. However, most brain banks are affected by low rates of subject enrollment. These low rates result in a lack of matching control cases, and long periods are needed to gather a reasonable amount of samples. Therefore, a cross-sectional design could solve some of the cited problems and even complement the other series through collaborations. We try to tackle the following questions/issues: (1) Is a cross-sectional brain bank in which clinical and functional assessment is based on CS information able to provide reliable data? 12.6% 8.2% 5.4% 8.1% CDR0 CDR 0.5 CDR 1 CDR 2 CDR 3 Fig. 6 Subject distribution according to the Clinical Rating Scale of Dementia. Brain Bank of the Brazilian Aging Brain Study Group Cognitive function is a difficult assessment area, especially in the absence of the subject. Therefore, aiming to gather reliable data from the CS, our protocol comprises only scales which are widely recognized as reliable for informantbased assessment (Morris et al. 1991; Jorm 1997; Winblad et al. 2004), including two cognitive scales: the IQCODE (Jorm 1994) and the CDR (Morris 1993). A study performed in Sao Paulo City verifies the IQCODE high sensitivity and specificity to the local population (Bustamante et al. 2003). Furthermore, evidence demonstrates these scales to be reliable even for subjects having mild cognitive impairment (Isella et al. 2006). An assessment done by experienced gerontologists is considered as accurate as one done by physicians (McCulla et al. 1989). (2) Is the period during autopsy suitable for clinical and functional assessment? Both the previous pilot studies and the current experience demonstrate that CSs are cooperative and provide accurate information in this period. Around 90% of the families voluntarily consent to participate, and just 15% of the assessments are reassigned for a few days later. (3) Is a structured brain bank affordable in local research conditions? USPMS is a government-supported school. The BBBABSG is sponsored by grants from the Pathology Department and minor grants from

11 Cell Tissue Banking (2007) 8: the Brazilian Research Institutes; SPAS structure and staff is paid by public funds. Moreover, the majority of the collecting and storing procedures are performed by supervised undergraduate biomedical students enrolled in a certificated Research Training Program. These students spend 20 h per week in training, and 30% of that time is dedicated to BBBABSG. The students receive a scholarship, and the remaining time is dedicated to their research projects, seminars and lectures. Those students are more academically prepared and motivated than technicians. Furthermore, several requests for grants are under evaluation by both national and international associations, as well as private companies which might benefit from tax breaks. Conclusions The high percentage of control subjects and the ethnic diversity of this series might make a significant contribution toward understanding aging brain processes and related neurodegenerative diseases. BBBABSG is not another brain bank in competition with the established facilities; rather, BBBABSG outcomes may provide investigators the answers to some additional questions. Finally, the BBBABSG series has the potential to advance the knowledge and understanding of the mechanisms underlying aging brain processes and related neurodegenerative diseases. Acknowledgements We are grateful to Prof. H. Heinsen (Julius Maximilians University Wurzburg, Germany) and to Larenda Mielke (Washington University in St Louis, USA) for them critical review. We also thank Sao Paulo Autopsy Service physicians and staff for unconditional support, BBASG s students for outstanding assistance and the staff of Pathology Department of University of Sao Paulo Medical School for technical support.support for this work was provided by grants from the Pathology Department and Geriatrics Division of University of Sao Paulo Medical School Research and Teaching Institute of Albert Einstein Hospital (Sao Paulo), Toxicology Department of Butantan Institute (Sao Paulo), Coordenadoria de Apoio ao Pessoal de Nivel Superior CAPES Scholarship (to LTG), and Fundação de Apoio à Pesquisa do Estado de São Paulo FAPESP Scholarship (to LTG). References Almeida P, Wickerhauser H (1991) [O Critério ABA/ ABIPEME em Busca de Uma Atualização. Um estudo e uma proposta submetidos à ABA e à ABI- PEME]. Editora da Associação Brasileira dos Institutos de Pesquisa de Mercado, Sao Paul Sao Paulo Braak H, Braak E (1991) Neuropathological stageing of alzheimer-related changes. Acta Neuropathol (Berl) 82: Braak H, Ghebremedhin E, Rub U et al (2004) Stages in the development of Parkinson s disease-related pathology. Cell Tissue Res 318(1): Brasil Conselho Nacional de Saúde (1996) [Resolução n 196 de 10 de outubro de Diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos]. In: Diário Oficial da República Federativa do Brasil, Brasília Brentani H, Caballero OL, Camargo AA et al (2003) The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci USA 100: Bustamante SE, Bottino CM, Lopes MA et al (2003) [Combined instruments on the evaluation of dementia in the elderly: preliminary results]. Arq Neuropsiquiatr 61: Cruz-Sanchez FF, Tolosa E (1993) The need of a consensus for brain banking. J Neural Transm Suppl 39:1 4 Cummings JL, Mega M, Gray K et al (1994) The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: Declaration of Helsinki (1964) Ethical principles for medical research involving human subjects. Adopted by the 18th World Medical Assembly. Helsinki, Finland Del-Ben CM, Rodrigues CR, Zuardi AW (1996) Reliability of the Portuguese version of the structured clinical interview for DSM-III-R (SCID) in a Brazilian sample of psychiatric outpatients. Braz J Med Biol Res 29: Ferri CP, Prince M, Brayne C et al (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366: Harrison PJ (1996) Advances in post mortem molecular neurochemistry and neuropathology: examples from schizophrenia research. Br Med Bull 52: Herrera E Jr, Caramelli P, Silveira AS et al (2002) Epidemiologic survey of dementia in a communitydwelling Brazilian population. Alzheimer Dis Assoc Disord 16: Hulette C (2003) Brain banking in the United States. J Neuropathol Exp Neurol 62: Isella V, Villa L, Russo A et al (2006) Discriminative and predictive power of an informant report in mild cognitive impairment. J Neurol Neurosurg Psychiatr 77:

12 162 Cell Tissue Banking (2007) 8: Jorm AF (1994) A short form of the informant questionnaire on cognitive decline in the elderly (IQCODE): development and cross-validation. Psychol Med 24: Jorm AF (1997) Methods of screening for dementia: a meta-analysis of studies comparing an informant questionnaire with a brief cognitive test. Alzheimer Dis Assoc Disord 11: Katz S, Ford AB, Moskowitz RW et al (1963) Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychological function. JAMA 185: Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: Love S (2004) Post mortem sampling of the brain and other tissues in neurodegenerative disease. Histopathology 44: Luchsinger JA, Reitz C, Honig LS et al (2005) Aggregation of vascular risk factors and risk of incident alzheimer disease. Neurology 65: McCulla MM, Coats M, Van Fleet N et al (1989) Reliability of clinical nurse specialists in the staging of dementia. Arch Neurol 46: McKeith IG, Galasko D, Kosaka K et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: McKhann GM, Albert MS, Grossman M et al (2001) Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and pick s disease. Arch Neurol 58: Mirra SS, Heyman A, McKeel D et al (1991) The consortium to establish a registry for alzheimer s disease (CERAD). Part II. Standardization of the neuropathologic assessment of alzheimer s disease. Neurology 41: Morris JC (1993) The clinical dementia rating (CDR): current version and scoring rules. Neurology 43: Morris JC, McKeel DW Jr, Storandt M et al (1991) Very mild alzheimer s disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology 41: Murphy DD, Ravina B (2003) Brain banking for neurodegenerative diseases. Curr Opin Neurol 16: National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research (1978) The Belmont report: ethical principles and guidelines for the protection of human subjects of research. Washington Orr S, Alexandre E, Clark BJ et al (2005) Fourth meeting of the European network of research tissue banks future strategy to increase collaborations in the supply of human tissue for biomedical research. Cell Tissue Bank 6: Ravid R, Van Zwieten EJ, Swaab DF (1992) Brain banking and the human hypothalamus factors to match for, pitfalls and potentials. Prog Brain Res 93:83 95 Ravid R, Swaab DF, Van Zwieten EJ et al (1995). Controls are what makes a brain bank go round. In: Cruz- Sanchez F, Cuzner M, Ravid R (eds) Neuropathological diagnostic criteria for brain banking, biomedical and health research. IOS Press, Amsterdam, pp 4 13 Roulson J, Benbow EW, Hasleton PS (2005) Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology 47: Saito Y, Ruberu NN, Sawabe M et al (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63: Spitzer RL, Williams JB, Gibbon M et al (1992) The structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49 : Tanner C, Gilley D, Goetz C (1990) A brief screening questionnaire for Parkinsonism. Ann Neurol 28 : The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer s Disease (1997) Consensus recommendations for the postmortem diagnosis of alzheimer s disease. Neurobiol Aging 18:S1 S2 United Nations Population Division (2000) World population prospects revision United Nations, New York Winblad B, Palmer K, Kivipelto M et al (2004) Mild cognitive impairment beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment. J Intern Med 256:

Brain Bank of the Brazilian Aging Brain Study Group a Collection Focused in Human Control Cases

Brain Bank of the Brazilian Aging Brain Study Group a Collection Focused in Human Control Cases Brain Bank of the Brazilian Aging Brain Study Group a Collection Focused in Human Control Cases Lea Tenenholz Grinberg, M.D, Ph.D Associate Professor of Pathology University of the City of São Paulo Medical

More information

Southwest Brain Bank

Southwest Brain Bank Southwest Brain Bank Texas Tech University Health Sciences Center Paul L. Foster School of Medicine Department of Psychiatry Peter Thompson, M.D., M.S. Director Angelica Forero, M.A. Senior Research Scientist

More information

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril

Neuropathology of Neurodegenerative Disorders Prof. Jillian Kril Neurodegenerative disorders to be discussed Alzheimer s disease Lewy body diseases Frontotemporal dementia and other tauopathies Huntington s disease Motor Neuron Disease 2 Neuropathology of neurodegeneration

More information

The Spectrum of Age-Associated Astroglial Tauopathies. Dennis W. Dickson MD Department of Neuroscience Mayo Clinic, Jacksonville, FL

The Spectrum of Age-Associated Astroglial Tauopathies. Dennis W. Dickson MD Department of Neuroscience Mayo Clinic, Jacksonville, FL The Spectrum of Age-Associated Astroglial Tauopathies Dennis W. Dickson MD Mayo Clinic, Jacksonville, FL Thorn-shaped astrocytes TSA were first reported by Ikeda (1995), as tau-positive astrocytes in various

More information

Post-Mortem diagnosis of dementia by informant interview

Post-Mortem diagnosis of dementia by informant interview Original Article Post-Mortem diagnosis of dementia by informant interview Renata Eloah de Lucena Ferretti 1,2,3, Antonio Eduardo Damin 4,5, Sonia Maria Dozzi Brucki 4,5, Lilian Schafirovits Morillo 1,4,

More information

1. Middle frontal gyrus at the level of the genu of the corpus callosum.

1. Middle frontal gyrus at the level of the genu of the corpus callosum. 2008 Clinical Diagnosis: Dementia: (i) Alzheimer s disease (ii) Dementia with Lewy bodies (iii) Normal adult brain BrainNet Europe II Project Co-ordinator: Prof. Dr. Hans Kretzschmar Protocol: Block taking,

More information

NEUROPATHOLOGY BRAIN CUTTING MANUAL LAST UPDATED ON 6/22/2015

NEUROPATHOLOGY BRAIN CUTTING MANUAL LAST UPDATED ON 6/22/2015 NEUROPATHOLOGY BRAIN CUTTING MANUAL LAST UPDATED ON 6/22/2015 Neuropathology Faculty involved in Brain Cutting: Dr. Sandra Camelo-Piragua Dr. Andrew Lieberman (Chief of the Division) Dr. Kathryn A. McFadden

More information

Brain dissection protocol for amyotrophic lateral sclerosis/motor neurone disease

Brain dissection protocol for amyotrophic lateral sclerosis/motor neurone disease Brain dissection protocol for amyotrophic lateral sclerosis/motor neurone disease Prepared by Approved by Approved by Revised by Name Signature Date Sampling and biomarker OPtimization and Harmonization

More information

ALLEN Human Brain Atlas

ALLEN Human Brain Atlas TECHNICAL WHITE PAPER: CASE QUALIFICATION AND DONOR PROFILES The case review process described here was employed for three components of the ALLEN Human Brain Atlas: (1) the Survey; (2) the Neurotransmitter

More information

Alzheimer s Disease Neuroimaging Initiative

Alzheimer s Disease Neuroimaging Initiative Alzheimer s Disease Neuroimaging Initiative Steering Committee Meeting April 18, 2016 Neuropathology Core John C. Morris, MD Nigel J. Cairns, PhD, FRCPath Erin Franklin, MS Table 1. Participants Autopsied

More information

Baseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston

Baseline Characteristics of Patients Attending the   Memory Clinic Serving the South Shore of Boston Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,

More information

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago

UDS Progress Report. -Standardization and Training Meeting 11/18/05, Chicago. -Data Managers Meeting 1/20/06, Chicago UDS Progress Report -Standardization and Training Meeting 11/18/05, Chicago -Data Managers Meeting 1/20/06, Chicago -Training material available: Gold standard UDS informant and participant interviews

More information

Lewy Body-Related -Synucleinopathy in Aging

Lewy Body-Related -Synucleinopathy in Aging Journal of Neuropathology and Experimental Neurology Vol. 6, No. 7 Copyright 4 by the American Association of Neuropathologists July, 4 pp. 74 749 Lewy Body-Related -Synucleinopathy in Aging YUKO SAITO,

More information

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)

The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL) The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL Sue J. Kang, M.S., Seong Hye Choi, M.D.*, Byung H. Lee, M.A., Jay C. Kwon, M.D., Duk L. Na, M.D., Seol-Heui Han

More information

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES.

NEXT-Link DEMENTIA. A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA A network of Danish memory clinics YOUR CLINICAL RESEARCH PARTNER WITHIN ALZHEIMER S DISEASE AND OTHER DEMENTIA DISEASES. NEXT-Link DEMENTIA NEXT-Link DEMENTIA is a network of Danish

More information

NACC Neuropathology (NP) Diagnosis Coding Guidebook

NACC Neuropathology (NP) Diagnosis Coding Guidebook Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu

More information

Guidelines. for collecting post mortem brain tissue of cases with psychiatric diseases within the network

Guidelines. for collecting post mortem brain tissue of cases with psychiatric diseases within the network 2005 Introduction Our goal is to collect post mortem brain tissue from patients with schizophrenia, depression (unipolar and bipolar), dementia as well as healthy controls. To address this, we developed

More information

NACC Vascular Consortium. NACC Vascular Consortium. NACC Vascular Consortium

NACC Vascular Consortium. NACC Vascular Consortium. NACC Vascular Consortium NACC Vascular Consortium NACC Vascular Consortium Participating centers: Oregon Health and Science University ADC Rush University ADC Mount Sinai School of Medicine ADC Boston University ADC In consultation

More information

Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale

Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Seong Hye Choi, M.D.*, Duk L. Na, M.D., Byung Hwa Lee, M.A., Dong-Seog Hahm, M.D., Jee Hyang Jeong, M.D.,

More information

ORIGINAL CONTRIBUTION. Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease

ORIGINAL CONTRIBUTION. Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease ORIGINAL CONTRIBUTION Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease Vahram Haroutunian, PhD; Dushyant P. Purohit, MD; Daniel P. Perl, MD; Deborah Marin, MD; Khalid

More information

The Carroll A. Campbell, Jr. Neuropathology Laboratory: A Tool for Dementia Discovery in South Carolina

The Carroll A. Campbell, Jr. Neuropathology Laboratory: A Tool for Dementia Discovery in South Carolina The Carroll A. Campbell, Jr. Neuropathology Laboratory: A Tool for Dementia Discovery in South Carolina Pathology in the Cerebral Cortex H&E stain of mature neuritic plaque Modified Bielschowsky stain

More information

ORIGINAL CONTRIBUTION. Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease

ORIGINAL CONTRIBUTION. Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease ORIGINAL CONTRIBUTION Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer Disease Vahram Haroutunian, PhD; Daniel P. Perl, MD; Dushyant P. Purohit,

More information

Mild Cognitive Impairment (MCI)

Mild Cognitive Impairment (MCI) October 19, 2018 Mild Cognitive Impairment (MCI) Yonas E. Geda, MD, MSc Professor of Neurology and Psychiatry Consultant, Departments of Psychiatry & Psychology, and Neurology Mayo Clinic College of Medicine

More information

ORIGINAL CONTRIBUTION. Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic

ORIGINAL CONTRIBUTION. Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic ORIGINAL CONTRIBUTION Cerebrospinal Fluid -Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain Tero Tapiola, MD, PhD; Irina Alafuzoff, MD, PhD; Sanna-Kaisa Herukka,

More information

Alzheimer disease (AD) is a devastating neurodegenerative

Alzheimer disease (AD) is a devastating neurodegenerative ORIGINAL ARTICLE Rates of Depression in Individuals With Pathologic But Not Clinical Alzheimer Disease are Lower Than Those in Individuals Without the Disease: Findings From the Baltimore Longitudinal

More information

Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease

Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease Genetic Epidemiology 15:215 223 (1998) Validity of Family History for the Diagnosis of Dementia Among Siblings of Patients With Late-onset Alzheimer s Disease G. Devi, 1,3 * K. Marder, 1,3 P.W. Schofield,

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a preprint version which may differ from the publisher's version. For additional information about this

More information

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky

Type 2 Diabetes and Brain Disease in Older Adults. Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Type 2 Diabetes and Brain Disease in Older Adults Erin L. Abner, PhD, MPH Asst. Professor University Of Kentucky Disclosures to Participants Requirements for Successful Completion: For successful completion,

More information

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT

DISCLOSURES. Objectives. THE EPIDEMIC of 21 st Century. Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia NONE TO REPORT Clinical Assessment of Cognition: New & Emerging Tools for Diagnosing Dementia DISCLOSURES NONE TO REPORT Freddi Segal Gidan, PA, PhD USC Keck School of Medicine Rancho/USC California Alzheimers Disease

More information

NACC Minimum Data Set (MDS) Public Data Element Dictionary

NACC Minimum Data Set (MDS) Public Data Element Dictionary Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu

More information

25 th Annual Southern California Alzheimer s Disease Research Conference

25 th Annual Southern California Alzheimer s Disease Research Conference 25 th Annual Southern California Alzheimer s Disease Research Conference New Guidelines and Importance of Brain Donation Thomas J. Montine, MD, PhD Alvord Professor & Chair Department of Pathology University

More information

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA

Clinicopathologic and genetic aspects of hippocampal sclerosis. Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA Clinicopathologic and genetic aspects of hippocampal sclerosis Dennis W. Dickson, MD Mayo Clinic, Jacksonville, Florida USA The hippocampus in health & disease A major structure of the medial temporal

More information

Dementia and Healthy Ageing : is the pathology any different?

Dementia and Healthy Ageing : is the pathology any different? Dementia and Healthy Ageing : is the pathology any different? Professor David Mann, Professor of Neuropathology, University of Manchester, Hope Hospital, Salford DEMENTIA Loss of connectivity within association

More information

FDG-PET e parkinsonismi

FDG-PET e parkinsonismi Parkinsonismi FDG-PET e parkinsonismi Valentina Berti Dipartimento di Scienze Biomediche, Sperimentali e Cliniche Sez. Medicina Nucleare Università degli Studi di Firenze History 140 PubMed: FDG AND parkinsonism

More information

Synaptic changes in dementia: links to cognition and behaviour

Synaptic changes in dementia: links to cognition and behaviour Synaptic changes in dementia: links to cognition and behaviour Paul T Francis, PhD Professor of Neurochemistry Director, Brains for Dementia Research Agenda Discuss synaptic changes in various dementias

More information

! slow, progressive, permanent loss of neurologic function.

! slow, progressive, permanent loss of neurologic function. UBC ! slow, progressive, permanent loss of neurologic function.! cause unknown.! sporadic, familial or inherited.! degeneration of specific brain region! clinical syndrome.! pathology: abnormal accumulation

More information

Medical Neuroscience Tutorial Notes

Medical Neuroscience Tutorial Notes Medical Neuroscience Tutorial Notes Blood Supply to the Brain MAP TO NEUROSCIENCE CORE CONCEPTS 1 NCC1. The brain is the body's most complex organ. LEARNING OBJECTIVES After study of the assigned learning

More information

Parkinson s UK Brain Bank

Parkinson s UK Brain Bank Parkinson s UK Brain Bank From Brain to Breakthrough Dr George Gveric Manager 19 October 2018 Coordinated approach Donors Relatives Information Reporting Researchers Tissue supply Quality assurance Expertise

More information

Vascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES. VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology

Vascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES. VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology Vascular Cognitive Impairment-- NEUROPATHOLOGIC ISSUES VCI vs. IVD/DEMENTIA with VASCULAR DISEASE (IVD) advanced pathology HANDLING the BRAIN at AUTOPSY: What to FIX vs. what to FREEZE? --no need to be

More information

doi: /brain/awq141 Brain 2010: 133; Age, Alzheimer s disease and dementia in the Baltimore Longitudinal Study of Ageing

doi: /brain/awq141 Brain 2010: 133; Age, Alzheimer s disease and dementia in the Baltimore Longitudinal Study of Ageing doi:10.1093/brain/awq141 Brain 2010: 133; 2225 2231 2225 BRAIN A JOURNAL OF NEUROLOGY Age, Alzheimer s disease and dementia in the Baltimore Longitudinal Study of Ageing David Dolan, 1 Juan Troncoso, 2

More information

Anosognosia, or loss of insight into one s cognitive

Anosognosia, or loss of insight into one s cognitive REGULAR ARTICLES Anosognosia Is a Significant Predictor of Apathy in Alzheimer s Disease Sergio E. Starkstein, M.D., Ph.D. Simone Brockman, M.A. David Bruce, M.D. Gustavo Petracca, M.D. Anosognosia and

More information

Lewy body disease (LBD) is the second most common

Lewy body disease (LBD) is the second most common REGULAR ARTICLES Lewy Body Disease: Can We Diagnose It? Michelle Papka, Ph.D. Ana Rubio, M.D., Ph.D. Randolph B. Schiffer, M.D. Christopher Cox, Ph.D. The authors assessed the accuracy of published clinical

More information

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases

Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Role of TDP-43 in Non-Alzheimer s and Alzheimer s Neurodegenerative Diseases Keith A. Josephs, MD, MST, MSc Professor of Neurology 13th Annual Mild Cognitive Impairment (MCI) Symposium: Alzheimer and Non-Alzheimer

More information

Neuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens

Neuro-Imaging in dementia: using MRI in routine work-up Prof. Philip Scheltens Neuro-Imaging in dementia: Philip Scheltens Alzheimer Center VU University Medical Center Amsterdam The Netherlands 1 Outline of talk Current guidelines Imaging used to exclude disease Specific patterns

More information

Organization of The Nervous System PROF. SAEED ABUEL MAKAREM

Organization of The Nervous System PROF. SAEED ABUEL MAKAREM Organization of The Nervous System PROF. SAEED ABUEL MAKAREM Objectives By the end of the lecture, you should be able to: List the parts of the nervous system. List the function of the nervous system.

More information

Visual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London

Visual Rating Scale Reference Material. Lorna Harper Dementia Research Centre University College London Visual Rating Scale Reference Material Lorna Harper Dementia Research Centre University College London Background The reference materials included in this document were compiled and used in relation to

More information

Chronic Traumatic Encephalopathy Provider and Parent Essentials

Chronic Traumatic Encephalopathy Provider and Parent Essentials Chronic Traumatic Encephalopathy Provider and Parent Essentials Concussion Global Cast July 30, 2014 John Lockhart, MD Seattle Children s Hospital Chronic Traumatic Encephaly (CTE) Working Definition Chronic

More information

ORIGINAL CONTRIBUTION. Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia

ORIGINAL CONTRIBUTION. Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia ORIGINAL CONTRIBUTION Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical Dementia Gregory A. Jicha, MD, PhD; Joseph E. Parisi, MD; Dennis W. Dickson, MD; Kris Johnson,

More information

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative ORIGINAL RESEARCH E. Matsusue S. Sugihara S. Fujii T. Kinoshita T. Nakano E. Ohama T. Ogawa Cerebral Cortical and White Matter Lesions in Amyotrophic Lateral Sclerosis with Dementia: Correlation with MR

More information

Recent publications using the NACC Database. Lilah Besser

Recent publications using the NACC Database. Lilah Besser Recent publications using the NACC Database Lilah Besser Data requests and publications Using NACC data Number of requests by year Type 2009 2010 2011 2012 2013 2014 2015 Data files* 55 85 217 174 204

More information

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre

Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Yin-Hui Siow MD, FRCPC Director of Nuclear Medicine Southlake Regional Health Centre Today Introduction to CT Introduction to MRI Introduction to nuclear medicine Imaging the dementias The Brain ~ 1.5

More information

NIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2013 April 03.

NIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2013 April 03. NIH Public Access Author Manuscript Published in final edited form as: Arch Neurol. 2012 October ; 69(10): 1326 1331. doi:10.1001/archneurol.2012.1608. Pathologic Accumulation of α-synuclein and Aβ in

More information

BIOL Dissection of the Sheep and Human Brain

BIOL Dissection of the Sheep and Human Brain BIOL 2401 Dissection of the Sheep and Human Brain Laboratory Objectives After completing this lab, you should be able to: Identify the main structures in the sheep brain and to compare them with those

More information

Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical

Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical 161Journal of Neurology, Neurosurgery, and Psychiatry 1997;62:16-21 Alzheimer's Treatment and Research Center, Department of Neurology, Ramsey Clinic/Health- Partners, University of Minnesota, St Paul,

More information

Neuro degenerative PET image from FDG, amyloid to Tau

Neuro degenerative PET image from FDG, amyloid to Tau Neuro degenerative PET image from FDG, amyloid to Tau Kun Ju Lin ( ) MD, Ph.D Department of Nuclear Medicine and Molecular Imaging Center, Chang Gung Memorial Hospital ( ) Department of Medical Imaging

More information

Geriatric Neurology Program Requirements

Geriatric Neurology Program Requirements Geriatric Neurology Program Requirements Approved November 8, 2013 Page 1 Table of Contents I. Introduction 3 II. Institutional Support 3 A. Sponsoring Institution 3 B. Primary Institution 4 C. Participating

More information

Dissection of the Sheep Brain

Dissection of the Sheep Brain Dissection of the Sheep Brain Laboratory Objectives After completing this lab, you should be able to: 1. Identify the main structures in the sheep brain and to compare them with those of the human brain.

More information

Form D1: Clinician Diagnosis

Form D1: Clinician Diagnosis Initial Visit Packet Form D: Clinician Diagnosis NACC Uniform Data Set (UDS) ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by the clinician.

More information

Basic Standards for Residency Training in General Neurology

Basic Standards for Residency Training in General Neurology Basic Standards for Residency Training in General Neurology American Osteopathic Association and American College of Osteopathic Neurologists and Psychiatrists Revised 2/2003 Revised 7/2004 Revised 6/2006

More information

Organization of The Nervous System PROF. MOUSAED ALFAYEZ & DR. SANAA ALSHAARAWY

Organization of The Nervous System PROF. MOUSAED ALFAYEZ & DR. SANAA ALSHAARAWY Organization of The Nervous System PROF. MOUSAED ALFAYEZ & DR. SANAA ALSHAARAWY Objectives At the end of the lecture, the students should be able to: List the parts of the nervous system. List the function

More information

Mild Cognitive Impairment

Mild Cognitive Impairment Mild Cognitive Impairment Victor W. Henderson, MD, MS Departments of Health Research & Policy (Epidemiology) and of Neurology & Neurological Sciences Stanford University Director, Stanford Alzheimer s

More information

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018

Improving diagnosis of Alzheimer s disease and lewy body dementia. Brain TLC October 2018 Improving diagnosis of Alzheimer s disease and lewy body dementia Brain TLC October 2018 Plan for this discussion: Introduction to AD and LBD Why do we need to improve diagnosis? What progress has been

More information

The world is graying: Dementia is an alarming issue

The world is graying: Dementia is an alarming issue Guest Editorial Paper Sapkota et.al. N Sapkota, Fellowship (Geriatric Psychiatry) Associate Professor and Head, Department of Psychiatry B.P. Koirala Institute of Health Sciences, Dharan, Nepal The world's

More information

Abnormal Facehand Testing is Associated with Anosognosia in Patients with Neuropathologicallyconfirmed Alzheimer s Disease

Abnormal Facehand Testing is Associated with Anosognosia in Patients with Neuropathologicallyconfirmed Alzheimer s Disease Abnormal Facehand Testing is Associated with Anosognosia in Patients with Neuropathologicallyconfirmed Alzheimer s Disease Item Type Thesis Authors Derksen, Brenna Publisher The University of Arizona.

More information

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of

Dementia is a common neuropsychiatric disorder characterized by progressive impairment of Focused Issue of This Month Diagnosis and Treatment for Behavioral and Psychological Symptoms of Dementia Byoung Hoon Oh, MD Department of Psychiatry, Yonsei University College of Medicine E - mail : drobh@yuhs.ac

More information

BRAIN STEM AND CEREBELLUM..

BRAIN STEM AND CEREBELLUM.. Lecture Title: BRAIN STEM AND CEREBELLUM.. (CNS Block, Radiology) Dr. Hamdy Hassan Ass.Prof. Consultant Radiology Department KKHU King Saud University Lecture Objectives.. Students at the end of the lecture

More information

Biological Bases of Behavior. 3: Structure of the Nervous System

Biological Bases of Behavior. 3: Structure of the Nervous System Biological Bases of Behavior 3: Structure of the Nervous System Neuroanatomy Terms The neuraxis is an imaginary line drawn through the spinal cord up to the front of the brain Anatomical directions are

More information

Hallucinations and conscious access to visual inputs in Parkinson s disease

Hallucinations and conscious access to visual inputs in Parkinson s disease Supplemental informations Hallucinations and conscious access to visual inputs in Parkinson s disease Stéphanie Lefebvre, PhD^1,2, Guillaume Baille, MD^4, Renaud Jardri MD, PhD 1,2 Lucie Plomhause, PhD

More information

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS

FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS FRONTOTEMPORAL DEGENERATION: OVERVIEW, TRENDS AND DEVELOPMENTS Norman L. Foster, M.D. Director, Center for Alzheimer s Care, Imaging and Research Chief, Division of Cognitive Neurology, Department of Neurology

More information

DISSECTION OF THE SHEEP'S BRAIN

DISSECTION OF THE SHEEP'S BRAIN Sheep Brain Dissection Guide Page 1 DISSECTION OF THE SHEEP'S BRAIN Introduction The purpose of the sheep brain dissection is to familiarize you with the threedimensional structure of the brain and teach

More information

brain MRI for neuropsychiatrists: what do you need to know

brain MRI for neuropsychiatrists: what do you need to know brain MRI for neuropsychiatrists: what do you need to know Christoforos Stoupis, MD, PhD Department of Radiology, Spital Maennedorf, Zurich & Inselspital, University of Bern, Switzerland c.stoupis@spitalmaennedorf.ch

More information

The ABCs of Dementia Diagnosis

The ABCs of Dementia Diagnosis The ABCs of Dementia Diagnosis Dr. Robin Heinrichs, Ph.D., ABPP Board Certified Clinical Neuropsychologist Associate Professor, Psychiatry & Behavioral Sciences Director of Neuropsychology Training What

More information

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits

More information

3/20/13. :: Slide 1 :: :: Slide 39 :: How Is the Nervous System Organized? Central Nervous System Peripheral Nervous System and Endocrine System

3/20/13. :: Slide 1 :: :: Slide 39 :: How Is the Nervous System Organized? Central Nervous System Peripheral Nervous System and Endocrine System :: Slide 1 :: :: Slide 39 :: How Is the Nervous System Organized? Central Nervous System Peripheral Nervous System and Endocrine System The nervous system is organized into several major branches, each

More information

Student Lab #: Date. Lab: Gross Anatomy of Brain Sheep Brain Dissection Organ System: Nervous Subdivision: CNS (Central Nervous System)

Student Lab #: Date. Lab: Gross Anatomy of Brain Sheep Brain Dissection Organ System: Nervous Subdivision: CNS (Central Nervous System) Lab: Gross Anatomy of Brain Sheep Brain Dissection Organ System: Nervous Subdivision: CNS (Central Nervous System) Student Lab #: Date 1 Objectives: 1. Learn the main components making up a motor neuron.

More information

Curriculum. Course Number Course Name & Description Credits

Curriculum. Course Number Course Name & Description Credits Curriculum Fall Semester Professional Year 1 PAA 00 PAA 660 PAA 7060 PAA 70 Applied General Pathology Graduate level students will be required in addition to taking the regular examinations, to answer

More information

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline I. Geriatric Psychiatry Patient Care and Procedural Skills Core Competencies A. Geriatric psychiatrists shall

More information

Brain imaging for the diagnosis of people with suspected dementia

Brain imaging for the diagnosis of people with suspected dementia Why do we undertake brain imaging in dementia? Brain imaging for the diagnosis of people with suspected dementia Not just because guidelines tell us to! Exclude other causes for dementia Help confirm diagnosis

More information

Alzheimer's Disease Brain Failure, Stopping the Momentum. Katherine E. Galluzzi, DO, CMD, FACOFP dist.

Alzheimer's Disease Brain Failure, Stopping the Momentum. Katherine E. Galluzzi, DO, CMD, FACOFP dist. AOA/ACOFP 113th Annual Convention and Scientific Seminar Las Vegas, Nevada Alzheimer's Disease Brain Failure, Stopping the Momentum Katherine E. Galluzzi, DO, CMD, FACOFP dist. Monday, October 27, 2008

More information

GOALS AND OBJECTIVES FOR FORENSIC PATHOLOGY

GOALS AND OBJECTIVES FOR FORENSIC PATHOLOGY GOALS AND OBJECTIVES FOR FORENSIC PATHOLOGY BACKGROUND By the end of their residency program, anatomical pathology residents will have completed: Three (3) autopsy blocks within their PGY2 year (2 hospital

More information

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16

Diagnosis before NIA AA The impact of FDG PET in. Diagnosis after NIA AA Neuropathology and PET image 2015/10/16 The impact of FDG PET in degenerative dementia diagnosis Jung Lung, Hsu MD, Ph.D (Utrecht) Section of dementia and cognitive impairment Department of Neurology Chang Gung Memorial Hospital, Linkou, Taipei

More information

THE RELATIONSHIP OF PLAQUES, TANGLES, AND LEWY TYPE ALPHA SYNUCLEINOPATHY TO VISUAL HALLUCINATIONS IN PARKINSON S DISEASE AND ALZHEIMER S DISEASE

THE RELATIONSHIP OF PLAQUES, TANGLES, AND LEWY TYPE ALPHA SYNUCLEINOPATHY TO VISUAL HALLUCINATIONS IN PARKINSON S DISEASE AND ALZHEIMER S DISEASE THE RELATIONSHIP OF PLAQUES, TANGLES, AND LEWY TYPE ALPHA SYNUCLEINOPATHY TO VISUAL HALLUCINATIONS IN PARKINSON S DISEASE AND ALZHEIMER S DISEASE A Thesis submitted to the University of Arizona College

More information

Chapter 3. Structure and Function of the Nervous System. Copyright (c) Allyn and Bacon 2004

Chapter 3. Structure and Function of the Nervous System. Copyright (c) Allyn and Bacon 2004 Chapter 3 Structure and Function of the Nervous System 1 Basic Features of the Nervous System Neuraxis: An imaginary line drawn through the center of the length of the central nervous system, from the

More information

European Prevention of Alzheimer s Dementia (EPAD)

European Prevention of Alzheimer s Dementia (EPAD) European Prevention of Alzheimer s Dementia (EPAD) Ron Marcus, MD ISCTM Adaptive Design Workshop February 20, 2018 1 EPAD Goal The European Prevention of Alzheimer's Dementia (EPAD) project aims to develop

More information

Altered proteins in the aging brain

Altered proteins in the aging brain Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1182 Altered proteins in the aging brain ADILA ELOBEID ACTA UNIVERSITATIS UPSALIENSIS UPPSALA 2016 ISSN 1651-6206 ISBN

More information

T H E B E T T E R H E A L T H N E W S

T H E B E T T E R H E A L T H N E W S Dr. Paul G. Varnas & WholeHealthAmerica.com present V O L U M E 7, I S S U E 2 T H E B E T T E R H E A L T H N E W S F E B R U A R Y, 2 0 1 0 D E M E N T I A A N D E X E R C I S E L E T S H E A R I T F

More information

Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer s disease

Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer s disease International Psychogeriatrics: page 1 of 8 C 2009 International Psychogeriatric Association doi:10.1017/s1041610209009454 Frontotemporal dementia and dementia with Lewy bodies in a case-control study

More information

NEUROPSYCHOMETRIC TESTS

NEUROPSYCHOMETRIC TESTS NEUROPSYCHOMETRIC TESTS CAMCOG It is the Cognitive section of Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) The measure assesses orientation, language, memory, praxis, attention, abstract

More information

Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases

Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases J Neuropathol Exp Neurol Copyright Ó 2010 by the American Association of Neuropathologists, Inc. Vol. 69, No. 5 May 2010 pp. 442Y448 ORIGINAL ARTICLE Inverse Relationship Between Cerebrovascular Lesions

More information

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities

Re: Request for Information: Updating the Alzheimer s Disease-Related Dementias Research Priorities Public Policy Division 202.393.7737 p 1212 New York Ave NW 866.865.0270 f Suite 800 www.alz.org Washington, DC 20005 Roderick Corriveau, Ph.D. Program Director National Institute of Neurological Disorders

More information

The Center on Aging unites aging-related research, education, and clinical programs at the University of Utah to help people lead longer and more

The Center on Aging unites aging-related research, education, and clinical programs at the University of Utah to help people lead longer and more The Center on Aging unites aging-related research, education, and clinical programs at the University of Utah to help people lead longer and more fulfilling lives. By linking its faculty and programs,

More information

Imaging of Alzheimer s Disease: State of the Art

Imaging of Alzheimer s Disease: State of the Art July 2015 Imaging of Alzheimer s Disease: State of the Art Neir Eshel, Harvard Medical School Year IV Outline Our patient Definition of dementia Alzheimer s disease Epidemiology Diagnosis Stages of progression

More information

Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases

Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases Acta Neuropathol (2011) 122:737 745 DOI 10.1007/s00401-011-0880-5 ORIGINAL PAPER Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases Sriram Venneti John L. Robinson Subhojit

More information

Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease

Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease Predicting Lewy Body Pathology in a Community-Based Sample With Clinical Diagnosis of Alzheimer s Disease Debby Tsuang, MD, MSc, Kate Simpson, MPH, Eric B. Larson, MD, MPH, Elaine Peskind, MD, Walter Kukull,

More information

GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM

GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM GUIDELINES FOR POST PEDIATRICS PORTAL PROGRAM Psychiatry is a medical specialty that is focused on the prevention, diagnosis, and treatment of mental, addictive, and emotional disorders throughout the

More information

Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL

Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL This is a Sample version of the Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL The full version of the Alzheimer's Disease - Activities of Daily Living Inventory AD-ADL comes without

More information

Cerebral hemisphere. Parietal Frontal Occipital Temporal

Cerebral hemisphere. Parietal Frontal Occipital Temporal Cerebral hemisphere Sulcus / Fissure Central Precental gyrus Postcentral gyrus Lateral (cerebral) Parieto-occipital Cerebral cortex Frontal lobe Parietal lobe Temporal lobe Insula Amygdala Hippocampus

More information

Mapping cancer, cardiovascular and malaria research in Brazil

Mapping cancer, cardiovascular and malaria research in Brazil Brazilian Journal of Medical and Biological Research (2) 33: 853-867 Mapping cancer, cardiovascular and malaria research ISSN 1-879X Overview 853 Mapping cancer, cardiovascular and malaria research in

More information

Be a part of the solution.

Be a part of the solution. Be a part of the solution. Become a registered brain donor with the Wisconsin Brain Donor Program and join the fight against Alzheimer s disease. We created this brochure to help with decision making.

More information

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018

Emerging CSF and serum biomarkers in atypical dementia. Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018 Emerging CSF and serum biomarkers in atypical dementia Laksanun Cheewakriengkrai, MD. Phramongkutklao Hospital March 7 th, 2018 Biomarkers A characteristic that is objectively measured and evaluated as

More information